We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| ResMed Inc | NYSE:RMD | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -1.17 | -0.54% | 216.98 | 221.40 | 216.72 | 219.63 | 654,899 | 01:00:00 |
From May 2019 to May 2024
SAN DIEGO, April 2, 2015 /PRNewswire/ -- RESMED INC. (NYSE: RMD) today announced that it will report its third quarter of fiscal year 2015 results on Thursday, April 23, 2015, after the New York Stock Exchange market close. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.
The earnings call is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call can be accessed on ResMed's Investor Relations website at http://investor.resmed.com. Please go to this section of the website and click on the icon for the "Q3 2015 earnings webcast."
Please note that we are no longer using outside conference lines to access the earnings call.
International earnings webcast times will be:
|
9:30 p.m. |
London |
|
6:30 a.m. |
Sydney, Australia (April 24, 2015) |
A replay of the earnings webcast will be accessible on our website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from April 23, 2015 until May 7, 2015 at:
US: 630-652-3042 Outside US: +1 630-652-3042 Passcode: 39335543
About ResMed
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, COPD, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information, please visit the company's website at www.resmed.com.
Contacts
Investors:
Agnes Lee
Senior Director, Investor Relations
(858) 836-5971
investorrelations@resmed.com
Media:
Alison Graves
Director, Global Corporate Communications
(858) 836-6789
news@resmed.com
Logo - http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/resmed-to-announce-third-quarter-2015-results-300060456.html
SOURCE ResMed Inc.
Copyright 2015 PR Newswire
1 Year ResMed Chart |
1 Month ResMed Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
